EC Healthcare Further Issue Shares to Strategic Shareholder Dr. Cheng Chi Kong and Aspex...

EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, SEHK stock code: 2138), the largest non-hospital medical group...

Eisai Launches In-house Developed Anti-insomnia Drug Dayvigo (Lemborexant) In Hong Kong

First Launch For Dayvigo In Asia Outside Of Japan Eisai Co., Ltd. announced today that its Hong Kong subsidiary Eisai (Hong Kong) Co., Ltd. has...

EC Healthcare Announces FY2020/21 Annual Results

Revenue from Medical Services Surged 54.0% Revenue from Mainland Business Soared 52.5% Consolidates and Corporatizes Hong Kong Medical market Accelerates Deployment in Mainland China's Consumer Medical Services...

Kindstar Globalgene Proposed Listing on the Main Board of the Hong Kong Stock Exchange

Offer Price Between HK$8.60 and HK$9.78 per Share To Raise Proceeds Up to HK$1,947 and 2,214 Million A leading player in China's independent esoteric clinical testing...

Jacobson Pharma Announces FY2021 Annual Results

Declares Final Dividend of HK1.5 Cents Per Share Resilient Performance Albeit Market Challenges Jacobson Pharma Corporation Limited (Jacobson Pharma or the Company; Stock Code: 2633), a...

JBM Healthcare Announces FY2021 Annual Results

Adjusted Net Profit* Increases by 13.3% to HK$54.6 Million JBM (Healthcare) Limited (JBM Healthcare or the Group; Stock Code: 2161), a leading branded healthcare products...

Avantor Named Best Company in Bioprocessing Excellence for Single-use Solutions and Best Bioprocessing Supplier...

Avantor, a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies and applied materials industries, was...

Cofttek Announces Mass-Production and Supply of Urolithin A & B

Cofttek Holding Limited, a Chinese pharmaceutical manufacturer, will mass-produce and supply the latest Urolithin A & B product to dietary supplement companies from June...

Strategic Collaboration Memorandum between EC Healthcare and China Medical System Utilizes the Synergy of...

EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, SEHK stock code: 2138), the largest non-hospital medical group...

Dingdang Health raises US$220 million in new financing round

China's leading integrated online healthcare platform Dingdang Health announced today that it has raised US$220 million in its latest financing round. This round was...

Avantor Acquires RIM Bio; Expands Bioproduction Footprint into China

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied...

Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5%...

Contribution of Sales of New Products to Revenue Rises to 47.4% Driving Revenue Up by 16.4% Sino Biopharmaceutical Limited (Sino Biopharmaceutical or the Company, together with...

Two Products of Zhaoke Ophthalmology (6622.HK) Passed The On-Site Inspection for Drug Registration of...

Signifying Government Recognition in The Company's Quality Manufacturing System Zhaoke Ophthalmology Limited (stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and...

Agilex Biolabs Partners with Endpoints News on Deconvoluting Inflammation and Immunology for Clinical Trials

Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials is partnering with Endpoints News to share the latest on...

APOLLOMICS INC. ANNOUNCES OFFICIAL OPENING OF SHANGHAI BRANCH

Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that Apollomics Shanghai Branch...

Starting its Industrial Investment in Biotech Companies, China Medical System (HKG:867) has Accelerated its...

China Medical System Holdings Limited (HKG:867) (CMS or the Company) has been active in the market this year. From the acquisition of Luqa to...

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to...

Scivita Medical Technology Co., Ltd. ("civita Medical) today announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become...

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China –...

Hua Medicine (Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the treatment of Type 2 Diabetes (T2D) was...

Avance Clinical Invited to Present “Decentralized Trials – No Going Back” for Oracle Health...

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on...

Sanofi Renews Partnership with Cielo to Strengthen its Talent Acquisition Strategy in Asia

Cielo, the world's leading Recruitment Process Outsourcing (RPO) provider, has renewed its partnership with Sanofi, a global biopharmaceutical company, to help them hire the...